• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevalence of genitourinary and other climacteric symptoms in 61-year-old women.

作者信息

Stenberg A, Heimer G, Ulmsten U, Cnattingius S

机构信息

Department of Obstetrics and Gynecology, Uppsala University Hospital, Sweden.

出版信息

Maturitas. 1996 May;24(1-2):31-6. doi: 10.1016/0378-5122(95)00996-5.

DOI:10.1016/0378-5122(95)00996-5
PMID:8794431
Abstract

In a population-based cohort study, 1280 women, aged 61, were interviewed regarding their genitourinary and other postmenopausal symptoms by means of an anonymous questionnaire. The group selected was to constitute all women of 61 years of age living in Uppsala county, Sweden. The response rate was 84%. All were postmenopausal women. Seventy-three percent of the women answering admitted some degree of urinary incontinence and 33% more severe degree. Forty-nine percent reported some degree of stress incontinence, 25% a more severe degree. Thirty-one percent experienced urge incontinence, 14% severely. A minority (4%), had had more than two urinary infections during the last year. The majority (67%) had changed urinating habits, going to the toilet at night and a minority complained of increased frequency of micturation (8%). Of the participating women, 59% were still sexually active, 43% had trouble with vaginal dryness and 10% with vaginal burning. Vasomotor problems such as hot flushes (30%), daily (33%) and nightly sweating (36%) were all common troubles. Forty-seven percent of the women had asked for medical help for estrogen deficiency problems, 82% were satisfied with the help they had received. Thirty-four percent were on estrogen therapy, 16% had systemic therapy 18% low dose estrogen treatment.

摘要

相似文献

1
Prevalence of genitourinary and other climacteric symptoms in 61-year-old women.
Maturitas. 1996 May;24(1-2):31-6. doi: 10.1016/0378-5122(95)00996-5.
2
Prevalence of genito-urinary symptoms in the late menopause.绝经后期泌尿生殖系统症状的患病率
Acta Obstet Gynecol Scand. 1984;63(3):257-60. doi: 10.3109/00016348409155509.
3
A study on urogenital complaints of postmenopausal women aged 50 and over.一项关于50岁及以上绝经后女性泌尿生殖系统不适症状的研究。
Acta Obstet Gynecol Scand. 2005 Jan;84(1):72-8. doi: 10.1111/j.0001-6349.2005.00645.x.
4
Impact of urinary and climacteric symptoms on social and sexual life after surgical treatment of stress urinary incontinence in women: a long-term outcome.女性压力性尿失禁手术治疗后泌尿及更年期症状对社交和性生活的影响:长期结果
J Adv Nurs. 2001 Feb;33(3):316-27. doi: 10.1046/j.1365-2648.2001.01667.x.
5
[Gyneco-urologic problems in climacteric].[更年期的妇科泌尿问题]
Wien Med Wochenschr. 1992;142(5-6):115-9.
6
Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986.1986年瑞典林雪平60至62岁女性的更年期症状。
Maturitas. 1988 Oct;10(3):193-9. doi: 10.1016/0378-5122(88)90022-9.
7
Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years.
Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(1):9-14. doi: 10.1007/pl00004023.
8
Urinary incontinence and related urogenital symptoms in elderly women.老年女性的尿失禁及相关泌尿生殖系统症状
Acta Obstet Gynecol Scand Suppl. 1993;158:1-22. doi: 10.3109/00016349309156515.
9
The urogenital system and the menopause.泌尿生殖系统与更年期。
Climacteric. 2015;18 Suppl 1:18-22. doi: 10.3109/13697137.2015.1078206.
10
The role of estrogens in female lower urinary tract dysfunction.雌激素在女性下尿路功能障碍中的作用。
Urology. 2003 Oct;62(4 Suppl 1):45-51. doi: 10.1016/s0090-4295(03)00676-9.

引用本文的文献

1
Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review.绝经后女性阴道萎缩的注射治疗:系统评价。
Aesthetic Plast Surg. 2023 Dec;47(6):2788-2799. doi: 10.1007/s00266-023-03550-5. Epub 2023 Aug 14.
2
Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study.评估多点黏膜内阴道注射特定交联透明质酸治疗外阴阴道萎缩的效果:一项前瞻性双中心初步研究。
BMC Womens Health. 2021 Aug 28;21(1):322. doi: 10.1186/s12905-021-01435-w.
3
Treatment of genitourinary syndrome of menopause: the potential effects of intravaginal ultralow-concentration oestriol and intravaginal dehydroepiandrosterone on quality of life and sexual function.
更年期泌尿生殖综合征的治疗:阴道内超低浓度雌三醇和阴道内脱氢表雄酮对生活质量和性功能的潜在影响。
Prz Menopauzalny. 2019 Jun;18(2):116-122. doi: 10.5114/pm.2019.86836. Epub 2019 Jun 28.
4
Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women.健康绝经后女性连续21天经阴道环给药三种剂量雌三醇后的药代动力学和药效学
Br J Clin Pharmacol. 2019 Mar;85(3):551-562. doi: 10.1111/bcp.13822. Epub 2018 Dec 25.
5
Quality of life among postmenopausal women enrolled in the Minnesota Green Tea Trial.参加明尼苏达绿茶试验的绝经后妇女的生活质量。
Maturitas. 2018 Feb;108:1-6. doi: 10.1016/j.maturitas.2017.10.013. Epub 2017 Nov 2.
6
Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials.妇女健康倡议激素治疗试验干预后阶段的性活动与阴道症状
Menopause. 2018 Mar;25(3):252-264. doi: 10.1097/GME.0000000000000994.
7
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.五个欧洲国家中影响更年期症状治疗决策的行为和态度。
Post Reprod Health. 2016 Sep;22(3):112-22. doi: 10.1177/2053369116632439. Epub 2016 Feb 18.
8
A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.一项随机、双盲、安慰剂对照的2期试点试验,评估一种含有溶解雌二醇的新型阴道软胶囊。
Menopause. 2016 May;23(5):506-10. doi: 10.1097/GME.0000000000000592.
9
Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.在绝经后食蟹猕猴局部应用富含植物雌激素的草药葛根后,阴道萎缩得到改善且无全身副作用。
J Reprod Dev. 2014;60(3):238-45. doi: 10.1262/jrd.2013-144. Epub 2014 Apr 21.
10
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.组织选择性雌激素复合物:绝经症状综合管理的有前途选择。
Drugs Aging. 2010 Jul 1;27(7):533-44. doi: 10.2165/11316000-000000000-00000.